vs
Side-by-side financial comparison of HAEMONETICS CORP (HAE) and H2O AMERICA (HTO). Click either name above to swap in a different company.
HAEMONETICS CORP is the larger business by last-quarter revenue ($339.0M vs $199.4M, roughly 1.7× H2O AMERICA). HAEMONETICS CORP runs the higher net margin — 13.2% vs 8.1%, a 5.1% gap on every dollar of revenue. On growth, H2O AMERICA posted the faster year-over-year revenue change (1.5% vs -2.7%). Over the past eight quarters, H2O AMERICA's revenue compounded faster (15.3% CAGR vs 0.4%).
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen (Jack) Latham in the 1970s.
H2O Wireless is a United States-based prepaid cell phone service, that utilizes the AT&T network. It is a brand of the mobile virtual network operator (MVNO) Locus Telecommunications, a subsidiary of Telrite Holdings, Inc., since 2019. Locus was formerly a subsidiary of KDDI America corporation, starting in 2010. H2O Wireless is primarily advertised as a non-restrictive phone service for customers to bring or buy unlocked smartphones, although AT&T contract/locked phones may be accepted as well.
HAE vs HTO — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $339.0M | $199.4M |
| Net Profit | $44.7M | $16.2M |
| Gross Margin | 59.7% | — |
| Operating Margin | 19.9% | 16.6% |
| Net Margin | 13.2% | 8.1% |
| Revenue YoY | -2.7% | 1.5% |
| Net Profit YoY | 19.3% | -29.2% |
| EPS (diluted) | $0.95 | $0.45 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $339.0M | $199.4M | ||
| Q3 25 | $327.3M | $243.5M | ||
| Q2 25 | $321.4M | $197.8M | ||
| Q1 25 | $330.6M | $164.9M | ||
| Q4 24 | $348.5M | $196.5M | ||
| Q3 24 | $345.5M | $216.7M | ||
| Q2 24 | $336.2M | $173.1M | ||
| Q1 24 | — | $150.0M |
| Q4 25 | $44.7M | $16.2M | ||
| Q3 25 | $38.7M | $45.1M | ||
| Q2 25 | $34.0M | $24.7M | ||
| Q1 25 | $58.0M | $16.6M | ||
| Q4 24 | $37.5M | $22.9M | ||
| Q3 24 | $33.8M | $38.7M | ||
| Q2 24 | $38.4M | $20.7M | ||
| Q1 24 | — | $11.7M |
| Q4 25 | 59.7% | — | ||
| Q3 25 | 59.5% | — | ||
| Q2 25 | 59.8% | — | ||
| Q1 25 | 58.4% | — | ||
| Q4 24 | 55.5% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 52.0% | — | ||
| Q1 24 | — | — |
| Q4 25 | 19.9% | 16.6% | ||
| Q3 25 | 17.9% | 26.5% | ||
| Q2 25 | 16.8% | 22.2% | ||
| Q1 25 | 21.6% | 21.8% | ||
| Q4 24 | 16.9% | 22.2% | ||
| Q3 24 | 15.0% | 26.9% | ||
| Q2 24 | 11.8% | 23.4% | ||
| Q1 24 | — | 18.6% |
| Q4 25 | 13.2% | 8.1% | ||
| Q3 25 | 11.8% | 18.5% | ||
| Q2 25 | 10.6% | 12.5% | ||
| Q1 25 | 17.5% | 10.0% | ||
| Q4 24 | 10.8% | 11.7% | ||
| Q3 24 | 9.8% | 17.8% | ||
| Q2 24 | 11.4% | 12.0% | ||
| Q1 24 | — | 7.8% |
| Q4 25 | $0.95 | $0.45 | ||
| Q3 25 | $0.81 | $1.27 | ||
| Q2 25 | $0.70 | $0.71 | ||
| Q1 25 | $1.17 | $0.49 | ||
| Q4 24 | $0.74 | $0.70 | ||
| Q3 24 | $0.66 | $1.17 | ||
| Q2 24 | $0.74 | $0.64 | ||
| Q1 24 | — | $0.36 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $363.4M | $20.7M |
| Total DebtLower is stronger | $1.2B | $1.9B |
| Stockholders' EquityBook value | $911.5M | $1.5B |
| Total Assets | $2.5B | $5.1B |
| Debt / EquityLower = less leverage | 1.34× | 1.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $363.4M | $20.7M | ||
| Q3 25 | $296.4M | $11.3M | ||
| Q2 25 | $292.9M | $19.8M | ||
| Q1 25 | $306.8M | $23.7M | ||
| Q4 24 | $320.8M | $11.1M | ||
| Q3 24 | $299.3M | $4.0M | ||
| Q2 24 | $344.4M | $22.8M | ||
| Q1 24 | — | $4.5M |
| Q4 25 | $1.2B | $1.9B | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.2B | — | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $911.5M | $1.5B | ||
| Q3 25 | $849.2M | $1.5B | ||
| Q2 25 | $882.3M | $1.5B | ||
| Q1 25 | $820.8M | $1.4B | ||
| Q4 24 | $906.9M | $1.4B | ||
| Q3 24 | $878.9M | $1.3B | ||
| Q2 24 | $905.4M | $1.3B | ||
| Q1 24 | — | $1.2B |
| Q4 25 | $2.5B | $5.1B | ||
| Q3 25 | $2.4B | $5.0B | ||
| Q2 25 | $2.5B | $4.8B | ||
| Q1 25 | $2.5B | $4.7B | ||
| Q4 24 | $2.5B | $4.7B | ||
| Q3 24 | $2.5B | $4.6B | ||
| Q2 24 | $2.5B | $4.4B | ||
| Q1 24 | — | $4.4B |
| Q4 25 | 1.34× | 1.23× | ||
| Q3 25 | 1.44× | — | ||
| Q2 25 | 1.39× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | — | 1.26× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $93.6M | $63.5M |
| Free Cash FlowOCF − Capex | $87.2M | — |
| FCF MarginFCF / Revenue | 25.7% | — |
| Capex IntensityCapex / Revenue | 1.9% | — |
| Cash ConversionOCF / Net Profit | 2.09× | 3.92× |
| TTM Free Cash FlowTrailing 4 quarters | $308.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.6M | $63.5M | ||
| Q3 25 | $111.3M | $77.3M | ||
| Q2 25 | $17.4M | $60.8M | ||
| Q1 25 | $116.6M | $43.2M | ||
| Q4 24 | $43.8M | $41.5M | ||
| Q3 24 | $48.8M | $53.5M | ||
| Q2 24 | $-27.4M | $49.3M | ||
| Q1 24 | — | $51.2M |
| Q4 25 | $87.2M | — | ||
| Q3 25 | $106.3M | — | ||
| Q2 25 | $13.6M | — | ||
| Q1 25 | $100.9M | — | ||
| Q4 24 | $35.2M | — | ||
| Q3 24 | $39.4M | — | ||
| Q2 24 | $-33.1M | — | ||
| Q1 24 | — | — |
| Q4 25 | 25.7% | — | ||
| Q3 25 | 32.5% | — | ||
| Q2 25 | 4.2% | — | ||
| Q1 25 | 30.5% | — | ||
| Q4 24 | 10.1% | — | ||
| Q3 24 | 11.4% | — | ||
| Q2 24 | -9.8% | — | ||
| Q1 24 | — | — |
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.5% | — | ||
| Q2 25 | 1.2% | — | ||
| Q1 25 | 4.7% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 2.7% | — | ||
| Q2 24 | 1.7% | — | ||
| Q1 24 | — | — |
| Q4 25 | 2.09× | 3.92× | ||
| Q3 25 | 2.88× | 1.71× | ||
| Q2 25 | 0.51× | 2.47× | ||
| Q1 25 | 2.01× | 2.61× | ||
| Q4 24 | 1.17× | 1.81× | ||
| Q3 24 | 1.44× | 1.39× | ||
| Q2 24 | -0.71× | 2.38× | ||
| Q1 24 | — | 4.38× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
HAE
| Hospital | $143.5M | 42% |
| Plasma Productsand Services | $138.9M | 41% |
| Blood Center Productsand Services | $56.6M | 17% |
HTO
| Water Utility Services | $191.0M | 96% |
| Other | $8.4M | 4% |
